Dianthus Therapeutics, Inc.DNTHNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-78.28M
↓ 72% below average
Average (8y)
$-45.61M
Historical baseline
Range
High:$-6.67M
Low:$-78.28M
CAGR
+36.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-78.28M | -111.7% |
| 2023 | $-36.97M | -26.6% |
| 2022 | $-29.21M | +52.0% |
| 2021 | $-60.80M | +5.6% |
| 2020 | $-64.42M | -7.1% |
| 2019 | $-60.16M | -21.4% |
| 2018 | $-49.56M | -102.6% |
| 2017 | $-24.46M | -266.9% |
| 2016 | $-6.67M | - |